Inhibition of Choroidal Neovascularization via Brief Subretinal Exposure to a Newly Developed Lentiviral Vector Pseudotyped with Sendai Viral Envelope Proteins-Reference-Cited by-同舟云学术

Inhibition of Choroidal Neovascularization via Brief Subretinal Exposure to a Newly Developed Lentiviral Vector Pseudotyped with Sendai Viral Envelope Proteins

Published:2010-02 Issue:2 Volume:21 Page:199-209
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Murakami Yusuke¹²,Ikeda Yasuhiro¹,Yonemitsu Yoshikazu³,Miyazaki Masanori¹,Inoue Makoto⁴,Hasegawa Mamoru⁴,Sueishi Katsuo²,Ishibashi Tatsuro¹

Affiliation:

1. Department of Ophthalmology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.

2. Division of Pathophysiological and Experimental Pathology, Department of Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.

3. Department of Gene Therapy, Chiba University Graduate School of Medicine, Chiba 260-8670, Japan.

4. DNAVEC, Tsukuba City, Ibaraki 305-0856, Japan.

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/hum.2009.102

Reference66 articles.

1. Gene therapy restores vision in a canine model of childhood blindness

2. Intravitreal Bevacizumab (Avastin) for Neovascular Age-Related Macular Degeneration

3. Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1